Kiniksa Pharmaceuticals: GAAP EPS de -$ 0,06 perde por US$ 0,01, receita de US$ 108,63 milhões supera em US$ 17,36 milhões
Kiniksa Pharmaceuticals: GAAP EPS de -$ 0,06 perde por US$ 0,01, receita de US$ 108,63 milhões supera em US$ 17,36 milhões
Our mission is to deliver accurate, timely, and comprehensive news coverage that keeps our readers informed and engaged. We aim to provide a balanced perspective on the latest events and issues shaping our world, offering insightful analysis and in-depth reporting on a wide range of topics.
© 2024 Best Debt Secrets . All Rights Reserved.